JAK2 and acute lymphoblastic leukemia: Together, these data indicate that the constitutively active Pax5‐Jak2 kinase maintains active STAT5 at high levels in the nucleus, thus leading to continuous expression of STAT5 target genes in Pax5Jak2/+ B‐ALL cells.